Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
disease | 0.400 | None | 1.000 | 163 | 332 | 1991 | 2017 | ||||||||
|
RPL36A-HNRNPH2 readthrough | 0.861 | 0.154 | 0.36 |
|
disease | 0.100 | None | 1.000 | 162 | 135 | 1989 | 2018 | ||||||||
|
galactosidase alpha | 0.537 | 0.769 | 1.00 |
|
disease | 1.000 | definitive | 0.992 | 162 | 135 | 1967 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
disease | 1.000 | definitive | 0.984 | 162 | 101 | 1995 | 2020 | ||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
disease | 1.000 | definitive | 0.987 | 161 | 53 | 2001 | 2020 | ||||||||
|
solute carrier family 26 member 4 | 0.507 | 0.885 | 9.0E-22 |
|
disease | 1.000 | definitive | 1.000 | 156 | 128 | 1996 | 2019 | ||||||||
|
fibrillin 1 | 0.417 | 0.846 | 1.00 |
|
disease | 0.600 | definitive | 1.000 | 155 | 361 | 1973 | 2019 | ||||||||
|
lamin A/C | 0.384 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 154 | 87 | 1990 | 2018 | ||||||||
|
potassium voltage-gated channel subfamily Q member 1 | 0.485 | 0.769 | 4.5E-08 |
|
disease | 0.700 | None | 0.980 | 152 | 102 | 1993 | 2020 | ||||||||
|
myosin binding protein C3 | 0.593 | 0.385 | 8.0E-11 |
|
disease | 0.500 | None | 1.000 | 147 | 172 | 1989 | 2019 | ||||||||
|
transthyretin | 0.423 | 0.885 | 0.52 |
|
disease | 1.000 | None | 0.992 | 142 | 43 | 1983 | 2020 | ||||||||
|
mutS homolog 6 | 0.462 | 0.731 | 3.7E-05 |
|
disease | 0.800 | definitive | 0.987 | 140 | 238 | 1988 | 2020 | ||||||||
|
F-box protein 11 | 0.604 | 0.692 | 1.00 |
|
disease | 0.100 | None | 1.000 | 140 | 236 | 1997 | 2019 | ||||||||
|
methyl-CpG binding protein 2 | 0.414 | 0.846 | 0.89 |
|
disease | 1.000 | definitive | 0.977 | 132 | 316 | 1975 | 2020 | ||||||||
|
mutY DNA glycosylase | 0.521 | 0.769 | 1.3E-18 |
|
disease | 0.710 | definitive | 1.000 | 131 | 98 | 1987 | 2018 | ||||||||
|
MEFV innate immuity regulator, pyrin | 0.440 | 0.885 | 1.0E-14 |
|
disease | 1.000 | None | 0.993 | 130 | 26 | 1993 | 2020 | ||||||||
|
calpain 3 | 0.564 | 0.615 | 3.6E-19 |
|
disease | 1.000 | strong | 0.994 | 127 | 142 | 1995 | 2019 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.800 | definitive | 1.000 | 125 | 191 | 1972 | 2020 | ||||||||
|
potassium voltage-gated channel subfamily H member 2 | 0.522 | 0.731 | 1.00 |
|
disease | 0.500 | None | 0.990 | 120 | 114 | 1995 | 2020 | ||||||||
|
von Hippel-Lindau tumor suppressor | 0.443 | 0.846 | 8.0E-02 |
|
disease | 0.900 | None | 1.000 | 120 | 53 | 1976 | 2016 | ||||||||
|
NPC intracellular cholesterol transporter 1 | 0.518 | 0.692 | 6.5E-06 |
|
disease | 1.000 | strong | 0.994 | 118 | 139 | 1988 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 4 | 0.554 | 0.731 | 1.3E-02 |
|
disease | 1.000 | None | 1.000 | 116 | 27 | 1989 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 4 | 0.554 | 0.731 | 1.3E-02 |
|
disease | 0.110 | None | 1.000 | 116 | 27 | 1989 | 2018 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.500 | None | 0.971 | 113 | 49 | 1947 | 2019 | ||||||||
|
ATP binding cassette subfamily A member 4 | 0.493 | 0.769 | 5.3E-48 |
|
disease | 1.000 | None | 0.978 | 113 | 204 | 1997 | 2020 |